CA
NZ
UK
AU
IND
US
The Tradr 2X Long IBM Daily ETF (Cboe: IBX) seeks daily investment results, before fees and expenses, corresponding to approximately 200% (2x long) of the daily performance of International Business Machines Corporation (NYSE: IBM). The ETF is designed to provide traders with amplified bullish exposure to IBM, allowing investors to potentially capitalize on short-term price movements driven by enterprise artificial intelligence (AI) adoption, hybrid cloud expansion, consulting growth, quantum computing advancements, software innovation, and increased enterprise technology spending.
International Business Machines Corporation (IBM) is one of the world's largest enterprise technology companies, providing hybrid cloud infrastructure, AI software, consulting services, cybersecurity solutions, automation platforms, quantum computing technologies, and mission-critical IT infrastructure. Through its Red Hat acquisition and continued investments in generative AI, IBM has strengthened its position as a leading provider of enterprise AI solutions for governments, financial institutions, healthcare organizations, manufacturers, and multinational corporations.
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
Past performance is not a reliable indicator of future performance.
Please wait processing your request...